Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05540262
NA
Edaravone in the Treatment of Optic Neuritis
Sponsor: First Affiliated Hospital of Guangxi Medical University
View on ClinicalTrials.gov
Summary
Edaravone has demonstrated a beneficial effect in promoting remyelination and protecting axons in animals with NMOSD. The researchers posit that edaravone may enhance visual outcomes in patients with aquaporin-4 antibody-positive optic neuritis.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2022-01-15
Completion Date
2025-12-31
Last Updated
2025-02-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Edaravone
Edaravone injection 30mg three times a day
Locations (1)
Yi Du
Nanning, China